chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu symptoms (fever, non-stop sneezing, runny nose, itchy eyes, sinus congestion, pounding headache, flushing, generalized body aches) and soreness of left deltoid at injection site and weakness of left arm. Duration approximately 60+ hours.
Shortness of breath; I can barely walk half a block; Progressively worse with each shot; This spontaneous case was reported by a patient and describes the occurrence of DYSPNOEA (Shortness of breath), GAIT DISTURBANCE (I can barely walk half a block) and CONDITION AGGRAVATED (Progressively worse with each shot) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath), GAIT DISTURBANCE (I can barely walk half a block) and CONDITION AGGRAVATED (Progressively worse with each shot). At the time of the report, DYSPNOEA (Shortness of breath) had not resolved and GAIT DISTURBANCE (I can barely walk half a block) and CONDITION AGGRAVATED (Progressively worse with each shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products were not reported. It was reported that patient received spikevax bivalent vaccine dose 5 on 18-oct-2022 intramuscular route. Batch number was unknown for all the doses. Patient had Shortness of Breath. Over time developed into severe shortness of breath. Now at point patient can barely walk half a block. People keep asking if in need of help. Progressively worse with each shot. Started shortly after first short and worse after each shot. It was unknown if the patient experienced any additional symptoms/events.  Treatment medications were not reported.   This case was linked to MOD-2023-718857 (Patient Link).
This spontaneous report as received from a physician and a registered nurse refers to a 73 year old male patient. The concurrent condition included psoriasis, high blood pressure and skin cancer. Drug allergies included eye swelling with CARAC. On 18-MAY-2016, the patient was vaccinated with ZOSTAVAX (route, dose and details unavailable) (medication error-patient with skin cancer was administered ZOSTAVAX). Concomitant therapies included aspirin (manufacturer unknown) and amlodipine. It was reported that the physician would like to begin therapy with PICATO for an unspecified reason in the patient as soon as possible (Adverse event NOS). No lab tests were done. The patient sought medical attention by calling the physician. The outcome of adverse event was not resolved. The causality was unspecified. Additional information has been requested.
About 1 hr after receiving flu shot, patient started to wheeze, have tightness in throat and cough. She used Albuterol and also took a BENADRYL. She also threw up and felt faint. Lasted for about 4-5 hours.
Patient states that on 11/13/11 she developed a severe bloody nose that would not really stop and also noticed petechiae and wet purpura on her cheeks and tongue.  On 11/14/11 she contacted her OB/GYN then presented to the ED.  She states that she has had a history of some minor nosebleeds in the last few weeks but none prior to this pregnancy.  She denies any recent illnesses.  She had received a flu vaccination on 11/1/11, otherwise she has been previously healthy with no other changes to condition or medications.  She had no issues with bleeding in the past that she is aware of.  Patient's platelets on 9/23/11 were 223,000.  On presentation platelets were <5,000.  The patient is diagnosed with idiopathic thrombocytopenic purpura.  She was intiated on Prednisolone 70 mg PO daily and IVIG 70 grams daily for 2 doses.  Today is day 2 of therapy.
p/vax pt exp paleness, vomiting x2; chills; abdominal cramping; temp?; tx advil; also exp local react on 8/5-redness, warmth, swelling of rt arm; tx: benadryl & advil
Fever at about 100, fatigue, body aches, soreness at injection site. Got rest and drank fluids. Symptoms lasted for approximately 1 day.
At 9PM on day of administration, left arm became painful, swollen, and slight discolored lump at site extending to chest. At 11:45 AM, pain and swelling had decreased and pt prescribed APAP 500mg and Diphenhydramine 25mg.
Patient states that he received Janssen Covid-19 vaccine on 3/31/2021 and was exposed to a covid-19 positive co-worker on 4/2/2021 and tested positive for Covid-19 on 4-10-2021.  The patient came to the hospital emergency room via EMS on 4/21/2021 at 0912 complaining of shortness of breath. According to EMS the patient had an O2 saturation of 57% on room air and was place on CPAP, 15 liters, and transported to the ER.
Low grade fever and varicella-like rash in typical chicken pox distribution first appearing on 08/19/2017 (10 days after vaccination).
Pt recvd 3 doses of Engerix-B on 23JAN91; 27FEB91 & 30JUL91 & 23OCT91 lab test indicated did not convert; recvd a booster dose of Engerix-B on 23OCT91; 4DEC91 lab test indicated pt did convert;
extreme pain at the injection site; extreme pain at the injection site/could barely lift her arm without having a sharp pain/could barely move it, it felt very heavy; This is a spontaneous report from a contactable consumer. A 23-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot No: EL 3247), via an unspecified route of administration on the left arm on 28Jan2021 10:15 at single dose for covid-19 immunisation. Medical history included asthma and anaemia. The patient previously took amoxicillin, advil [ibuprofen], ibuprofen and experienced Allergies to medications. Patient received the vaccine on Thursday, 28Jan2021. That night she had extreme pain at the injection site. She could barely lift her arm without having a sharp pain. It felt like she could barely move it, it felt very heavy. Even when not moving my arm, there was a dull burning pain that was present. This pain continued into the next day, Friday, 29Jan2021. On Friday night, the pain was slowly subsiding. On Saturday, 30Jan2021, there was still a dull pain but she was able to move her arm and do daily activities again and she felt a lot better. On Sunday, 31Jan2021 her arm was completely normal again and there was no more pain. The patient received no treatment.  Outcome of the events was recovered on 31Jan2021.
diagnosed with COVID; diagnosed with COVID; This is a spontaneous report from a contactable consumer or other non hcp. A 62 year old female patient received the first dose of  bnt162b2 (BNT162B2, Solution for injection) via an unspecified route of administration on 27Mar2021as SINGLE DOSE and was scheduled for her second dose on 17Apr2021 for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On or about 17Apr2021, the patient underwent lab tests and procedures and diagnosed with covid positive which was considered serious as medically significant with an unknown outcome. Further patient asked if she can still take the second dose after more than 21 days. It was reported that patients husband also had COVID and was supposed to get vaccinated but had to cancel his appointment because of his diagnosis. The action taken in response to the event for bnt162b2 was not applicable. Follow up needed, further information was requested. information about lot/batch number needed.
Patient began experiencing a painful left shoulder by afternoon on the day of her injection. She was diagnosed with bursitis of her left shoulder. It became progressively worse and she is currently continuing in physical therapy.
Body ache; Weakness; Low grade fever; Headache; Muscle pain; Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 05Apr2021 at 11:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 10Mar2021 at 11:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05Apr2021 at 16:00, the patient experienced low grade fever, headache, muscle pain, joint pain, weakness and body ache. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of low grade fever, headache, muscle pain, joint pain, weakness and body ache were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
7x8 cm red hot area surrounding center of DTap injection developed 48 hr post injection.
Chest pain; Pericarditis; This spontaneous case was reported by a consumer and describes the occurrence of PERICARDITIS (Pericarditis) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Family history included Heart disease, unspecified.   In June 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jun-2021, the patient experienced CHEST PAIN (Chest pain). In June 2021, the patient experienced PERICARDITIS (Pericarditis) (seriousness criterion medically significant). The patient was treated with IBUPROFEN for Adverse event, at a dose of High dose, qid. At the time of the report, PERICARDITIS (Pericarditis) and CHEST PAIN (Chest pain) outcome was unknown.            No relevant concomitant medications were provided.  Reportedly, the patient experienced chest pain and went to the hospital where he was diagnosed with pericarditis.  Treatment medication also included steroids.  Company Comment: This case concerns a male of unknown age hospitalized with a serious unexpected event of pericarditis, and nonserious chest pain. Event onset during the week following second dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns a male of unknown age hospitalized with a serious unexpected event of pericarditis, and nonserious chest pain. Event onset during the week following second dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
On day vaccination was given, I experienced a sore arm.  Within 12 hours, I developed mild chills and mild nausea.  The day after my vaccination my arm soreness was 10/10.  It felt like someone shot me with a gun or hit me with a baseball going 150 mph at the injection site.  By the end of day 3 after the injection, I was almost symptom free with just a hint of soreness at the injection site.  By day four, I felt I was entirely back to normal.  However,  5 days after the Covid 19 Moderna 1st dose, I felt soreness under my armpit in the injected arm.  The next day, I had very large swelling under my armpit.  Today, seven days after the vaccine, my swelling in my armpit is not reduced and it is very tender.  The swelling is bulging and it is plainly visible.  There is no hard, distinct, lump that does not move.  Rather it is a large swollen area under the arm that may be pressed upon (although this is uncomfortable.)
2 days after 1st anthrax shot, pt started having joint pains and headaches which have continues x8 days. Seen on 1/27/2003 by Dr. Labs ordered, medications ordered: Fluticasone, salsalate. Pt referred to Hospital for Infectious disease/internal med consult.
Local reaction 1cm diameter of warm, erythematous, swelling and blotchy red/white rash below injection site on thigh to knee.
Information has been received from a physician concerning a 6 month old patient who on 21-SEP-2006 was vaccinated with an oral first dose of rotavirus reassortant vaccine live (human-bovine). The physician reported no side effect or problems. No product quality complaint was involved. Additional information has been requested.
Pt received PNEUMOVAX to Rt upper arm on 4/29/08. The next day, woke up with swelling and tender of injection site. Symptoms progressed and migrated down to his Rt hand and fingers, on 5/1/2008 and admitted to another hospital that day.  9/02/2008 MR received for DOS 5/1-3/2008 with D/C Dx: Cellulits of the R upper extremity. Pt presented with fever, chills, pain, redness and swelling of the RUE Pneumovax injection site. PE (+) for swelling and erythema from shoulder to wrist. Dx with cellulitis after DVT r/o. Started on abx.  Redness and swelling decreased and pt d/c on po abx.
Patient received first dose 08/14/21, had symptoms of light headedness and diaphoresis 2 days later with menorrhagia. She was seen in the ER. She was found to be anemic. Was prescribed iron supplements. She received her second dose 3 weeks later and again had menorrhagia. She was seen in the ER a week later with menorrhagia and severe anemia. She came back the next day and required a blood transfusion and a D and C.  She wsas in the hospital for 3 days. She has a history of heavy mentrual bleeding.
Information has been received from a registered pharmacist concerning a 63 year old male physician with diabetes and hypertension and a history of brain neoplasm (in remission for past 2 to 4 years), and no allergies who on 03-AUG-2009 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 664027/0136Y). Concomitant therapy included glyburide, lisinopril, (LIPITOR), (DIAZEPAN), sitagliptin phosphate, tablet and (AMBIEN). Subsequently the physician developed paralysis of his face. The physician did not want this reported but the physician's wife came to the pharmacy and reported it to the pharmacist. The physician called his physician but had not been seen. There were no laboratory studies performed. At the time of report, the physician had not recovered. Upon internal review, the paralysis of his face was determined to  be an other important event. Additional information has been requested.
This may be nothing, but I have seen other women with similar issues after the vaccination, so I thought it would be best to report it, just in case.  I am 47 years old and very likely perimenopausal. My cycle was between 32-35 days, fairly consistently. After my second dose, my period came a full week early, was heavier, and I had more cramping. Now I have just had my second period after my second shot, and it came after 28 days. So it seems like my cycle has shortened. Again, this may be a coincidence, but my periods have always been in the 32-35 day cycle range, very rarely under 30. It's unusual for me to have three periods so close together like this.
Mother states patient went home and took a nap and when she woke up her arm was hurting her really bad and she was shaky and was having shortness of breath. Mother rook her to urgent care, her O2 was 88% on RA and was put on oxygen via nasal canula her O2 went up from 88% to 90%  and was given a DECADRON 8mg/ml she received 1 mg IM PA-C on right gluteus. Patient declined EPI and BENADRYL injections. Urgent care wanted to have her transported to Hospital VIA ambulance but patient refused due to her starting to feel better.
Information has been received from a physician concerning a 19 weeks old patient who on 24-FEB-2011 was orally vaccinated with the first dose of ROTATEQ (Lot# and expiration not reported). The physician reported that inadvertently the patient was given ROTATEQ by mouth by the patient was over 15 weeks old. Physician reported that the patient was born on 26-SEP-2010 and the patient received the first dose of ROTATEQ on 24-FEB-2011. No adverse effects reported. At the time of reporting the patient's outcome was unknown. Additional information has been requested.
At about 9:00 PM, six hours after receiving the vaccine, my sense of well-being shifted dramatically, and I immediately went to bed. For the next three hours, my entire body constantly shook, with every muscle in my torso shaking explosively. For much of the time, AFIB was experienced and didn't end until about noon today. I did not have tachycardia.   If the phenomenon can be called chills, it is the worse occurrence I've ever experienced. I became weak and, several times, couldn't muster the strength to get out of bed, and when I did had trouble standing. Headache accompanied the experience. The picture in my mind was of being rolled about ferociously in a large metal drum. Surprisingly, the seemingly non-stop muscle convulsing did not precipitate a cold sweat. My skin was hot but seemed relatively dry.   My temperature rose four degrees from the 97.9 recorded before our medical visit and still has not settled to my average level. In addition, I drank 36 ounces of water over 8 hours and voided less than eight during that time. Testing for COVID this morning returned a negative result.
INR jumped to 3.9/INR was 3.5/INR was 2.1; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INTERNATIONAL NORMALISED RATIO FLUCTUATION (INR jumped to 3.9/INR was 3.5/INR was 2.1) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Historical condition reported). Concomitant products included WARFARIN SODIUM (COUMADIN) for an unknown indication.    On 26-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced INTERNATIONAL NORMALISED RATIO FLUCTUATION (INR jumped to 3.9/INR was 3.5/INR was 2.1). At the time of the report, INTERNATIONAL NORMALISED RATIO FLUCTUATION (INR jumped to 3.9/INR was 3.5/INR was 2.1) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, International normalised ratio: 3.9 (Inconclusive) INR jumped to 3.9. On 05-Feb-2021, International normalised ratio: 3.5 (Inconclusive) INR was 3.5. On 09-Feb-2021, International normalised ratio: 2.1 (Inconclusive) INR dropped to 2.1.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Arm hurting from first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE PAIN (Arm hurting from first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jul-2021, the patient experienced VACCINATION SITE PAIN (Arm hurting from first dose). At the time of the report, VACCINATION SITE PAIN (Arm hurting from first dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications details were provided. No Treatment Medications details were provided. Pharmacist called regarding a patient who received both doses of Moderna Vaccine but his arm was still hurting from his first dose when getting the second one on the same arm. Pharmacist wanted to know if patient can take painkillers.
The patient developed one large hive at the injection site in her upper left thigh. The hive developed to the size of a grapefruit. This began the same day as the vaccination and continued through 06/19/2001. No treatment was given.
vertebra bones in their lower back is worn from damage; extreme pain; cannot walk; symptoms felt on the left buttocks; symptoms felt on the left leg; This spontaneous case was reported by a patient and describes the occurrence of SPINAL COLUMN INJURY (vertebra bones in their lower back is worn from damage), BACK PAIN (extreme pain), GAIT INABILITY (cannot walk), MUSCULOSKELETAL PAIN (symptoms felt on the left buttocks) and PAIN IN EXTREMITY (symptoms felt on the left leg) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2022, the patient experienced SPINAL COLUMN INJURY (vertebra bones in their lower back is worn from damage), BACK PAIN (extreme pain), GAIT INABILITY (cannot walk), MUSCULOSKELETAL PAIN (symptoms felt on the left buttocks) and PAIN IN EXTREMITY (symptoms felt on the left leg). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, SPINAL COLUMN INJURY (vertebra bones in their lower back is worn from damage), BACK PAIN (extreme pain), GAIT INABILITY (cannot walk), MUSCULOSKELETAL PAIN (symptoms felt on the left buttocks) and PAIN IN EXTREMITY (symptoms felt on the left leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  Reportedly, patient had Cortisone injection in the back as the vertebra bones in patient's lower back was worn from  damage that caused extreme pain and patient could not walk. The patient did not have the back condition until May-2022.   Reporter did not allow further contact
had URI sx w/OM & conjunctivitis @ time of vax; presented 24 hrs later w/fever to 104, poor appetitie & excessive somnolence w/tachycardia, tachyapnea; full septic workup done & pt adm to hosp dx RSV pneumonia;
improperly stored vaccine involved in a temperature excursion; no additional AE reported; This spontaneous report was received from a medical assistant referring to a patient of unspecified age and gender. Information regarding medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies was not provided.   On an unspecified date, the patient was administered an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) as prophylaxis (dose, route of administration, and anatomical site of vaccination were not reported; lot number W006595 has been verified to be valid, expiration date reported and established as 10-OCT-2024).   It was reported that the vaccine was involved in a temperature excursion of 57.49 degrees Fahrenheit for 1 hour and 45 minutes (product storage error). No additional adverse event reported (no adverse event).